Ashni Naturaceuticals Acquires BioNexus Genomics, Developer of Patent-pending Genomic/Proteomic/Signal Transduction Technology.Business Editors/Health &Medical Writers SALT LAKE CITY--(BW HealthWire)--Jan. 25, 2000 Ashni Naturaceuticals Inc., has completed its acquisition of BioNexus Genomics Inc. of Ithaca, N.Y., the originator of the BIOprinting(TM) process, which utilizes a combination of genomic and proteomic analysis to develop proprietary dietary supplements Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement and functional foods. &uot;The incorporation of the Genomic BIOprinting(TM) process provides Ashni with a technology platform superior to any currently applied to the development of botanical/nutritional formulations,&uot; said Dinesh C. Patel, Ph.D., Ashni chairman, president and chief executive officer. &uot;What will make some brands stand above the rest will depend largely upon the results of clinical studies indicating efficacy, potency potency /po·ten·cy/ (po´ten-se) 1. the ability of the male to perform coitus. 2. the relationship between the therapeutic effect of a drug and the dose necessary to achieve that effect. 3. standardization standardization In industry, the development and application of standards that make it possible to manufacture a large volume of interchangeable parts. Standardization may focus on engineering standards, such as properties of materials, fits and tolerances, and drafting , and manufacturing quality. Companies having patent protected, clinically effective products will have the opportunity to thrive in this crowded market place,&uot; said Patel. &uot;With the addition of genomic, proteomic and signal transduction Signal transduction The transmission of molecular signals from a cell's exterior to its interior. Molecular signals are transmitted between cells by the secretion of hormones and other chemical factors, which are then picked up by different cells. technologies, Ashni will standardize stan·dard·ize v. 1. To cause to conform to a standard. 2. To evaluate by comparing with a standard. quality and discover patentable combination products with proven synergistic effect Synergistic effect A violation of value-additivity in that the value of a combination is greater than the sum of the individual values. . Pairing our unique products with controlled release and alternative delivery technologies will provide one more proprietary layer of protection. &uot;Clinical testing of Ashni's natural products will further validate our formulations, demonstrating safety and efficacy,&uot; said Jill T. Turner, Ashni vice president of business development. &uot;Whereas standard formulation procedures require foreknowledge fore·knowl·edge n. Knowledge or awareness of something before its existence or occurrence; prescience. foreknowledge Noun knowledge of something before it actually happens Noun 1. of the mechanism of action, Genomic BIOprinting(TM) actually uncovers the mechanism of action in process. Our method no longer requires separation technology. &uot;Quantification of all biologically active components takes place simultaneously. BIOprinting(TM) rapidly characterizes the safety index, potential drug-supplement interactions, and the probability of successful clinical outcome,&uot; said BIOprinting(TM) inventor John G. Babish, Ph.D., Ashni executive vice president of research and development. Ashni Naturaceuticals Inc., with its corporate headquarters in Salt Lake City, and primary laboratory facilities in Ithaca specializes in the research, development and marketing of clinically tested and patent-protected naturaceutical products. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion